LESLIE OLDHAM: Open Payments
NPI 1164880506 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 30 payments from 11 companies in 2025. Trend: 2023 $15 · 2024 $134 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 10 | $243 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $106 |
| Sumitomo Pharma America, Inc. | 3 | $85 |
| MILLICENT US INC | 2 | $50 |
| Exeltis, USA Inc. | 2 | $48 |
| Astellas Pharma US Inc | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| CooperSurgical, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: ZURZUVAE, MYFEMBREE, FEMLYV, SLYND, Veozah, APTIMA, Qelbree, Paragard T 380A.
Industry payments across CA — which companies pay providers there.
